Acupuncture and moxibustion review reports improvements in cancer-related fatigue
Randomized trials reported less fatigue, while varied methods and small samples leave the size, reliability and safety of any benefit uncertain.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reports that acupuncture, moxibustion or their combination improved cancer-related fatigue in the included trials. However, it does not provide a pooled effect size or enough detail about control treatments to judge the magnitude of benefit. Reports of no adverse events also cannot establish that these approaches are safe for every patient.
The authors identify limited sample sizes and differences in study methods. Abstract-only access also leaves the definitions of response, control care and adverse-event monitoring unclear.
Fatigue was the measured outcome
Trials used several validated fatigue questionnaires, so the outcomes concerned cancer-related tiredness. Treatment schedules ranged from short courses to longer regimens or chemotherapy-linked cycles, making the interventions difficult to describe as a single uniform treatment.
Response ranges need context
The abstract presents response-rate ranges across studies without explaining a shared definition of response. Those ranges should not be combined into an overall benefit estimate or used to rank acupuncture against moxibustion.
The original publication
Integrating English and Chinese evidence on acupuncture and moxibustion for cancer-related fatigue (CRF): a decade of research and clinical recommendations.
Tan ST, Tan SM, Chan SY et al.
Support Care Cancer · 2026
- PubMed ID
- 41721832
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.